Chemours (CC) PT Lowered to $14 at RBC Capital
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $15.97 +1.78%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
RBC Capital analyst Arun Viswanathan lowered the price target on Chemours (NYSE: CC) to $14.00 (from $17.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Barclays Downgrades Swiss Prime Site AG (SPSN:SW) (SWPRF) to Equalweight
- TAG Immobilien AG (TEG:GR) PT Raised to EUR17.30 at Barclays
- NIBE Industrier AB (NIBEB:SW) (NDRBF) PT Lowered to SEK27 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
